Matches in Wikidata for { <http://www.wikidata.org/entity/Q65385151> ?p ?o ?g. }
Showing items 1 to 52 of
52
with 100 items per page.
- Q65385151 description "clinical trial" @default.
- Q65385151 description "ensayu clínicu" @default.
- Q65385151 description "klinisch onderzoek" @default.
- Q65385151 description "клінічне випробування" @default.
- Q65385151 description "կլինիկական փորձարկում" @default.
- Q65385151 name "Establish The Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets (ACTFAST)" @default.
- Q65385151 name "Establish The Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets" @default.
- Q65385151 type Item @default.
- Q65385151 label "Establish The Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets (ACTFAST)" @default.
- Q65385151 label "Establish The Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets" @default.
- Q65385151 prefLabel "Establish The Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets (ACTFAST)" @default.
- Q65385151 prefLabel "Establish The Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets" @default.
- Q65385151 P1050 Q65385151-004C6C8D-224B-4035-95A4-CD28B3A7012A @default.
- Q65385151 P1050 Q65385151-1D4A7969-8DB5-48A0-B117-3540BDC933AE @default.
- Q65385151 P1050 Q65385151-99EFF75A-DC76-42D1-B20D-2B0F4350BE75 @default.
- Q65385151 P1050 Q65385151-9D7A05D0-059A-437B-9380-D482F327768F @default.
- Q65385151 P1132 Q65385151-71ADD46E-20AB-4180-8C0C-DD379FE3544D @default.
- Q65385151 P1476 Q65385151-6F2134E1-3E3E-4B04-B941-65E0C45F72F8 @default.
- Q65385151 P17 Q65385151-0E6AB92D-D3F5-4BA4-AB03-C61109F88B68 @default.
- Q65385151 P17 Q65385151-41049D97-35F9-4F5F-A259-2DF1FBCD0C9B @default.
- Q65385151 P17 Q65385151-AD0113C2-5887-42F7-8520-0DE6BCFE268F @default.
- Q65385151 P17 Q65385151-CC7A631D-40A6-4A2E-B37D-EB31892D454F @default.
- Q65385151 P17 Q65385151-DB428DD0-EFC3-4A8D-8879-F27E6931FE17 @default.
- Q65385151 P1813 Q65385151-5D63DC00-A777-4D9D-91AF-A113D8C067B2 @default.
- Q65385151 P2899 Q65385151-26211EE4-9E77-4DF2-9EEC-0DF753314EA1 @default.
- Q65385151 P3098 Q65385151-8923B8BC-14DA-4A59-94BA-73DDCE48A3A3 @default.
- Q65385151 P31 Q65385151-F24A6A58-4BAE-417E-BB4E-55A5B774933D @default.
- Q65385151 P580 Q65385151-3AFDA62F-DEB1-4EB2-8C9A-70170F6969CB @default.
- Q65385151 P582 Q65385151-CD09921E-E482-48F0-A50A-AD67E5AF2D53 @default.
- Q65385151 P6099 Q65385151-3FD65F57-2F98-48D0-8CB9-41D99637294A @default.
- Q65385151 P6153 Q65385151-3D086256-B0C9-420D-918D-1E1E69B9300D @default.
- Q65385151 P8363 Q65385151-4898B203-3E52-4671-ACA4-9CC08D25F22F @default.
- Q65385151 P1050 Q12202 @default.
- Q65385151 P1050 Q12206 @default.
- Q65385151 P1050 Q184559 @default.
- Q65385151 P1050 Q844935 @default.
- Q65385151 P1132 "+2080" @default.
- Q65385151 P1476 "ACTFAST: Achieve Cholesterol Targets Fast With Atorvastatin Stratified Titration. A Multicenter, Twelve-Week Treatment, Single Step Titration, Open-Label Study Assessing The Percentage Of Dyslipidemic High-Risk Patients Achieving Low Density Lipoprotein Cholesterol (LDL-C) Target With Atorvastatin Starting Doses Of 10 Mg, 20 Mg, 40 Mg, And 80 Mg" @default.
- Q65385151 P17 Q1009 @default.
- Q65385151 P17 Q145 @default.
- Q65385151 P17 Q16 @default.
- Q65385151 P17 Q29 @default.
- Q65385151 P17 Q38 @default.
- Q65385151 P1813 "ACTFAST" @default.
- Q65385151 P2899 "+18" @default.
- Q65385151 P3098 "NCT00442845" @default.
- Q65385151 P31 Q30612 @default.
- Q65385151 P580 "2003-01-01T00:00:00Z" @default.
- Q65385151 P582 "2004-02-01T00:00:00Z" @default.
- Q65385151 P6099 Q42825046 @default.
- Q65385151 P6153 Q206921 @default.
- Q65385151 P8363 Q78089383 @default.